Developer docs
API playgroundTry for free, no card

Search company profiles

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie

Full company profile

uuid00239rh

Namestring
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie
Legal namestring
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V.
Websiteurl
dgho.de
Company typeenum
Private
Founded yearint
1937
Descriptiontext

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO) is a German professional medical society (eingetragener Verein – registered association) founded in 1937 and headquartered in Berlin. It serves physicians and scientists specializing in hematology and medical oncology, functioning as Germany's leading professional body in the field and a significant voice in national healthcare policy. The organization runs 30+ working groups covering specialty topics from AI to palliative care, a quarterly member circular, and health policy publication series addressing drug shortages, demographic change, and AMNOG early benefit assessments.

DGHO's core digital asset is Onkopedia, a freely accessible guidelines portal providing diagnostic and therapeutic guidance for hematological and oncological diseases. The platform comprises a main portal with expert-developed guidelines, a parallel knowledge database of nearly 400 articles across 86 topics, a drug information system covering nearly 100 medications including AMNOG early benefit assessments and interaction/side-effect databases, and a mobile application launched in 2018 for offline access on iOS and Android. Complementary products include the eLCH eLearning Curriculum Hematology with a digitized specimen collection, the Junge DGHO youth program with mentoring and the Juniorakademie, the DGHO KI School training program on artificial intelligence, an Off-Label-Indikation database, and named scientific prizes and stipends.

The organization generates revenue primarily through annual membership fees (regulated by a separate fee schedule/Beitragsordnung), with members receiving reduced conference fees and full Onkopedia access. Additional revenue comes from conference participation and the DGHO Service GmbH subsidiary, which handles event organization, KI School, eLCH webinars, and intensive care training. The society co-organizes a joint annual conference with the Austrian (OeGHO) and Swiss (SGMO, SGH) sister societies, with the 2026 edition in Vienna attracting 806 submitted abstracts. Governance rests with a board led by Geschäftsführende Vorsitzende Prof. Dr. med. Claudia Baldus, alongside a chairman (Prof. Dr. med. Lars Bullinger) and board members.

Short descriptiontext

German professional medical society (eingetragener Verein) serving hematologists and oncologists through the Onkopedia guidelines portal (~400 articles, ~100 drug monographs), an annual conference, working groups, and educational programs, funded via membership fees and the DGHO Service GmbH subsidiary.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical practice guidelines, medical professional society, hematology oncology education, drug information database, continuing medical education
SIC code1 code
  • Services-Health Services8000
Product category
Medical Professional Society Services
Revenue model1 record
1Membership Fees
TypeSubscription Recurring
Description

The society generates revenue through annual membership fees. Members receive benefits including reduced conference fees, full Onkopedia access, professional information, and network access to the professional society.

dgho.de
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Full membership with standard benefits
ModelSubscriptionBilling cadenceAnnual
Notes

Annual membership fee; members receive reduced conference fees, full Onkopedia access, professional information, and network access.

dgho.de
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1Onkopedia
Description

The guidelines portal of DGHO providing guidelines for diagnosis and therapy of hematological and oncological diseases, freely accessible

dgho.de
+4 more records
Core offering1 text field

DGHO is a German professional medical society that provides clinical practice guidelines, drug information, and educational resources for hematology and medical oncology through its Onkopedia digital platform. The society also runs an annual conference, continuing medical education programs, mentoring for young professionals, and health policy advocacy for the German-speaking medical community.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

DGHO operates a unified portfolio of professional medical resources centered on Onkopedia, a comprehensive guidelines portal. The Onkopedia platform includes the main portal, a mobile app launched in 2018, a knowledge database with ~400 articles, and a drug information database covering ~100 medications. Complementing Onkopedia are educational tools (eLCH eLearning Curriculum), professional development programs (mentoring, awards, stipends), an annual conference, and an off-label indication database. The organization functions as a professional society providing clinical guidelines, educational content, and health policy resources for hematology and oncology practitioners in German-speaking regions.

Product and service1 record
1Onkopedia
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1OeGHO (Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-10-09
Description

Austrian sister society co-organizing the joint annual conference. The 2026 annual conference in Vienna is a common congress of DGHO, OeGHO, SGMO (Swiss), and SGH, making it a major European hematology-oncology event.

dgho.de
2SGMO (Schweizerische Gesellschaft für Medizinische Onkologie)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-10-09
Description

Swiss Society for Medical Oncology co-organizing the joint annual conference with DGHO, OeGHO, and SGH.

dgho.de
3SGH (Schweizerische Gesellschaft für Hämatologie)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-10-09
Description

Swiss Society for Hematology co-organizing the joint annual conference with DGHO, OeGHO, and SGMO.

dgho.de
Strategic tierCoreTypeOthers
Description

A service company of DGHO located at the same Berlin office, providing additional services including event organization (KI School, eLCH webinars, intensive care training courses). Website: dgho-service.de

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest US-based professional society for oncology, publishing clinical guidelines, hosting ASCO Annual Meeting, and operating JCO/JCO Oncology Practice journals. Direct functional peer to DGHO in guideline publishing, conference organization, and member education for oncology professionals.

TypeDirect peer
Description

Leading European oncology society publishing clinical practice guidelines, hosting the ESMO Congress, and serving medical oncologists across Europe. Most directly comparable continental peer to DGHO in oncology guideline development, education, and congress operations.

3International Society of Hematology (ISH)
TypeBroad incumbent
Description

Global hematology society that organizes biennial World Congress and supports hematology education worldwide. Broader geographic scope than DGHO but similar professional-society function for hematologists.

TypeDirect peer
Description

European hematology society that publishes guidelines, hosts the EHA Congress, and provides educational programs across Europe. Directly mirrors DGHO's hematology mission with a pan-European footprint, making it both a peer and partial competitor for content and congress share.

TypeOthers
Description

EU regulator referenced extensively in Onkopedia drug information entries. Not a competitor but a key external data source whose labeling decisions feed directly into DGHO's drug information and AMNOG assessments.

TypeBroad incumbent
Description

US-based alliance of leading cancer centers that produces widely adopted oncology clinical practice guidelines used globally. Comparable to Onkopedia as a guidelines publisher but operates as a guideline consortium rather than a member-driven professional society.

7Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie (OeGHO)
TypeRegional player
Description

Austrian sister society of DGHO with overlapping mission and joint annual conference co-organization. Functionally identical in structure (professional society, guidelines, congress) but scoped to Austria rather than Germany.

TypeDirect peer
Description

Premier global hematology society producing clinical guidelines, publishing Blood, and hosting the ASH Annual Meeting. Closest peer to DGHO for the hematology half of its scope, with similar content, conference, and advocacy offerings.

TypeRegional player
Description

UK national hematology society producing clinical guidelines, hosting the BSH Annual Scientific Meeting, and providing member education. Comparable to DGHO's hematology half but UK-focused rather than German.

TypeOthers
Description

German umbrella association of medical scientific societies that coordinates S3 guideline development across specialties. DGHO participates in AWMF's guideline infrastructure, making AWMF both an enabler of DGHO's guideline work and an indirect collaborator/peer at the meta-society level.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie

Medical Professional Society Servicesdgho.de

German professional medical society (eingetragener Verein) serving hematologists and oncologists through the Onkopedia guidelines portal (~400 articles, ~100 drug monographs), an annual conference, working groups, and educational programs, funded via membership fees and the DGHO Service GmbH subsidiary.

What Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie does

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO) is a German professional medical society (eingetragener Verein – registered association) founded in 1937 and headquartered in Berlin. It serves physicians and scientists specializing in hematology and medical oncology, functioning as Germany's leading professional body in the field and a significant voice in national healthcare policy. The organization runs 30+ working groups covering specialty topics from AI to palliative care, a quarterly member circular, and health policy publication series addressing drug shortages, demographic change, and AMNOG early benefit assessments.

DGHO's core digital asset is Onkopedia, a freely accessible guidelines portal providing diagnostic and therapeutic guidance for hematological and oncological diseases. The platform comprises a main portal with expert-developed guidelines, a parallel knowledge database of nearly 400 articles across 86 topics, a drug information system covering nearly 100 medications including AMNOG early benefit assessments and interaction/side-effect databases, and a mobile application launched in 2018 for offline access on iOS and Android. Complementary products include the eLCH eLearning Curriculum Hematology with a digitized specimen collection, the Junge DGHO youth program with mentoring and the Juniorakademie, the DGHO KI School training program on artificial intelligence, an Off-Label-Indikation database, and named scientific prizes and stipends.

The organization generates revenue primarily through annual membership fees (regulated by a separate fee schedule/Beitragsordnung), with members receiving reduced conference fees and full Onkopedia access. Additional revenue comes from conference participation and the DGHO Service GmbH subsidiary, which handles event organization, KI School, eLCH webinars, and intensive care training. The society co-organizes a joint annual conference with the Austrian (OeGHO) and Swiss (SGMO, SGH) sister societies, with the 2026 edition in Vienna attracting 806 submitted abstracts. Governance rests with a board led by Geschäftsführende Vorsitzende Prof. Dr. med. Claudia Baldus, alongside a chairman (Prof. Dr. med. Lars Bullinger) and board members.

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie firmographics

Firmographics
Name
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie
Legal name
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V.
Website
https://dgho.de
Company type
Private
Founded year
1937
Operating status
Operating
Headcount range
1–10 employees
Short description
German professional medical society (eingetragener Verein) serving hematologists and oncologists through the Onkopedia guidelines portal (~400 articles, ~100 drug monographs), an annual conference, working groups, and educational programs, funded via membership fees and the DGHO Service GmbH subsidiary.
Ownership category
akta.pro rank

Where Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Membership Fees: The society generates revenue through annual membership fees. Members receive benefits including reduced conference fees, full Onkopedia access, professional information, and network access to the professional society.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualFull membership with standard benefits

Distribution channels3 records

Marketing channels5 records

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie product offering

Product offering

Core offering

DGHO is a German professional medical society that provides clinical practice guidelines, drug information, and educational resources for hematology and medical oncology through its Onkopedia digital platform. The society also runs an annual conference, continuing medical education programs, mentoring for young professionals, and health policy advocacy for the German-speaking medical community.

Product overview

DGHO operates a unified portfolio of professional medical resources centered on Onkopedia, a comprehensive guidelines portal. The Onkopedia platform includes the main portal, a mobile app launched in 2018, a knowledge database with ~400 articles, and a drug information database covering ~100 medications. Complementing Onkopedia are educational tools (eLCH eLearning Curriculum), professional development programs (mentoring, awards, stipends), an annual conference, and an off-label indication database. The organization functions as a professional society providing clinical guidelines, educational content, and health policy resources for hematology and oncology practitioners in German-speaking regions.

Differentiator

Problem solved

Functional benefit

Brands

  • Onkopedia: The guidelines portal of DGHO providing guidelines for diagnosis and therapy of hematological and oncological diseases, freely accessible
  • eLCH – eLearning Curriculum Hämatologie
  • Junge DGHO
  • DGHO KI School
  • Deutsche Stiftung für junge Erwachsene mit Krebs

Products and services

  • Onkopedia

Companies that use Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie

Customer profile

Segments1 record

Ideal customer profiles1 record

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • OeGHO (Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie)coreStrategic or Co-development Partner · 9 October 2026Austrian sister society co-organizing the joint annual conference. The 2026 annual conference in Vienna is a common congress of DGHO, OeGHO, SGMO (Swiss), and SGH, making it a major European hematology-oncology event.
  • SGMO (Schweizerische Gesellschaft für Medizinische Onkologie)coreStrategic or Co-development Partner · 9 October 2026Swiss Society for Medical Oncology co-organizing the joint annual conference with DGHO, OeGHO, and SGH.
  • SGH (Schweizerische Gesellschaft für Hämatologie)coreStrategic or Co-development Partner · 9 October 2026Swiss Society for Hematology co-organizing the joint annual conference with DGHO, OeGHO, and SGMO.
  • DGHO Service GmbHcoreOthersA service company of DGHO located at the same Berlin office, providing additional services including event organization (KI School, eLCH webinars, intensive care training courses). Website: dgho-service.de

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie competitors and assessment

Company assessment

Direct peers

  • American Society of Clinical Oncology (ASCO): Largest US-based professional society for oncology, publishing clinical guidelines, hosting ASCO Annual Meeting, and operating JCO/JCO Oncology Practice journals. Direct functional peer to DGHO in guideline publishing, conference organization, and member education for oncology professionals.
  • European Society for Medical Oncology (ESMO): Leading European oncology society publishing clinical practice guidelines, hosting the ESMO Congress, and serving medical oncologists across Europe. Most directly comparable continental peer to DGHO in oncology guideline development, education, and congress operations.
  • European Hematology Association (EHA): European hematology society that publishes guidelines, hosts the EHA Congress, and provides educational programs across Europe. Directly mirrors DGHO's hematology mission with a pan-European footprint, making it both a peer and partial competitor for content and congress share.
  • American Society of Hematology (ASH): Premier global hematology society producing clinical guidelines, publishing Blood, and hosting the ASH Annual Meeting. Closest peer to DGHO for the hematology half of its scope, with similar content, conference, and advocacy offerings.

Broad incumbents

  • International Society of Hematology (ISH): Global hematology society that organizes biennial World Congress and supports hematology education worldwide. Broader geographic scope than DGHO but similar professional-society function for hematologists.
  • National Comprehensive Cancer Network (NCCN): US-based alliance of leading cancer centers that produces widely adopted oncology clinical practice guidelines used globally. Comparable to Onkopedia as a guidelines publisher but operates as a guideline consortium rather than a member-driven professional society.

Others

  • European Medicines Agency (EMA): EU regulator referenced extensively in Onkopedia drug information entries. Not a competitor but a key external data source whose labeling decisions feed directly into DGHO's drug information and AMNOG assessments.
  • Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF): German umbrella association of medical scientific societies that coordinates S3 guideline development across specialties. DGHO participates in AWMF's guideline infrastructure, making AWMF both an enabler of DGHO's guideline work and an indirect collaborator/peer at the meta-society level.

Regional players

  • Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie (OeGHO): Austrian sister society of DGHO with overlapping mission and joint annual conference co-organization. Functionally identical in structure (professional society, guidelines, congress) but scoped to Austria rather than Germany.
  • British Society for Haematology (BSH): UK national hematology society producing clinical guidelines, hosting the BSH Annual Scientific Meeting, and providing member education. Comparable to DGHO's hematology half but UK-focused rather than German.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie social profiles

Digital presence

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie leadership team

Management profile

Number of profiles

Profiles4 records

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie

What does Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie do?

DGHO is a German professional medical society that provides clinical practice guidelines, drug information, and educational resources for hematology and medical oncology through its Onkopedia digital platform. The society also runs an annual conference, continuing medical education programs, mentoring for young professionals, and health policy advocacy for the German-speaking medical community.

Is Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie a public or private company?

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie founded?

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie was founded in 1937. It employs 1 to 10 people.

Where is Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie based?

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie is headquartered in Berlin, Germany, in the Europe region.

How does Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie make money?

One revenue line is on record: membership Fees.

Who are Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie's main competitors?

Direct peers on record are American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), European Hematology Association (EHA) and American Society of Hematology (ASH). Broad incumbents are International Society of Hematology (ISH) and National Comprehensive Cancer Network (NCCN). Others are European Medicines Agency (EMA) and Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Regional players are Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie (OeGHO) and British Society for Haematology (BSH).

Does Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie have an API?

No public API is recorded for Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales